ACCP collaborates with ASHP on Cardiology Pharmacy activities.

• Target Audience
• Series Overview
• Activity Overview
• Faculty, Content Matter Experts, Reviewers, Field Testers and Disclosures
• Learning Objectives
• Continuing Pharmacy Education Credit
• Recertification Credit
• Technical Requirements
• Commercial Support

These Literature Studies are designed to help board-certified pharmacists who are seeking recertification credit hours to maintain their Board of Pharmacy Specialties (BPS).

The Literature Study Module provides immediate access to peer-selected, contemporary articles that are relevant to specialty practice. After learners review the content, they must successfully complete an online assessment to earn recertification credit.

Release date: October 20, 2021
BCCP credit expiration date: April 19, 2022
ACPE credit expiration date: October 20, 2024

The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities. Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.

Module 1A: Updates in Atrial Fibrillation and Antithrombotics in Valvular and Peripheral Vascular Disease
This module focuses on updates in atrial fibrillation and antithrombotics in valvular and peripheral vascular disease.

Module 1B: Heart Failure/Cardiovascular Outcomes
This module focuses on cardiovascular outcomes with colchicine and empagliflozin, as well as new treatment options for heart failure.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.

These activities are part of the ACCP and ASHP professional development program for BCCP recertification approved by the BPS.

	J. Erin Ledford, Pharm.D., BCPS-AQ Cardiology, BCCP, BCCCP Cardiology Critical Care Clinical Specialist WakeMed Health & Hospitals Raleigh, North Carolina
	Mary Roth, Pharm.D., BCCP, BCPS Cardiovascular Clinical Pharmacist University of Virginia Medical Center Charlottesville, Virginia
	Ashley Schenk, Pharm.D., BCPS, BCCP Cardiology Clinical Pharmacist University of Kentucky HealthCare Lexington, Kentucky
	Kristin Watson, Pharm.D., BCCP Associate Professor University of Maryland School of Pharmacy Baltimore, Maryland

	Steven Dunn, Pharm.D., BCPS, BCCP, FCCP, FAHA Pharmacy Clinical Coordinator, Heart and Vascular University of Virginia Health System Charlottesville, Virginia
	Genevieve M. Hale, Pharm.D., BCPS, BCCP Assistant Professor and Vice-Chair Nova Southeastern University College of Pharmacy Palm Beach Gardens, Florida
	Michelle L. Hilaire, Pharm.D., FCCP, BCPS, BCACP, CDE Clinical Professor University of Wyoming Laramie, Wyoming
	Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP Associate Professor of Pharmacy Practice Jefferson College of Pharmacy Thomas Jefferson University Philadelphia, Pennsylvania
	Brent N. Reed, Pharm.D., BCPS, BCCP Associate Professor of Pharmacy Practice and Science University of Maryland School of Pharmacy Baltimore, Maryland
	Paul M. Szumita, Pharm.D., BCCCP, BCPS, FASHP, FCCM Director of Clinical Pharmacy Brigham & Women's Hospital Boston, Massachusetts

Faculty, Content Matter Experts, Reviewers, Field Testers and Disclosures

Module 1A: Updates in Atrial Fibrillation and Antithrombotics in Valvular and Peripheral Vascular Disease

Module 1B: Heart Failure/Cardiovascular Outcomes

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Module 1A: Updates in Atrial Fibrillation and Antithrombotics in Valvular and Peripheral Vascular Disease
Universal Activity Number: 0204-9999-21-979-H01-P
Contact Hours: 4.00
Activity Type: Application-Based

Module 1B: Heart Failure/Cardiovascular Outcomes
Universal Activity Number: 0204-9999-21-980-H01-P
Contact Hours: 4.00
Activity Type: Application-Based

Methods and CE Requirements

ACPE Continuing Pharmacy Education Credit
To be eligible to earn continuing pharmacy education credit, participants must purchase the product, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by October 20, 2024. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

Board certified pharmacists are eligible to receive up to 8 hours of recertification credit for completing this activity. To be eligible to earn BCCP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by April 19, 2022. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

The passing point to earn BCCP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCCP posttest deadline that meets this passing point will earn BCCP recertification credits. These credits will be assigned as of the date of test submission. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCCP recertification should be directed to BPS at (202) 429-7591 or www.bpsweb.org.

• Internet browser
• Adobe Reader (available free)

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.